Apollomics Impact Investors
Apollomics is a biopharmaceutical company discovering and developing mono- and combination- oncology therapies to harness the immune system.
Industry:
Innovation, Technology, and Research
Technology:
Data-driven Technologies
Funding Status:
Late Stage Venture
Estimated Revenue:
$1M to $10M
Headquarters:
Foster City, California, United States
Employee Number:
11-50
Founded Date:
2016